article thumbnail

AZmed’s AZchest Receives Two FDA Clearances for AI-Powered Software Applications

XTalks

European AI med tech company AZmed received two new FDA clearances for its AI-powered chest X-ray tool, AZchest. The FDA approved AZchest applications to detect lung nodules and triage cases involving pneumothorax and pleural effusion. The company rebranded the name of its AI suite from Rayvolve to AZchest.

article thumbnail

FDA okays ProstatID software for detecting prostate cancer in MRI

pharmaphorum

Magnetic resonance imaging (MRI) technology specialist Bot Image has won FDA approval for its artificial intelligence-powered software ProstatID, used for the detection and diagnosis of prostate cancer. The FDA approval means that “the path for implementation is open,” according to Jones.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Siemens Photon-Counting CT Scanner as First CT Upgrade in a Decade

XTalks

CT imaging is a key non-invasive medical tool used in the diagnosis and monitoring of disease and injury. With no major innovations in the field for nearly a decade, the new photon-scanning technology may transform CT imaging by making it more detailed and efficient by drastically improving image quality.

article thumbnail

First Non-Surgical Heart Valve Wins FDA Approval for Severe Pulmonary Valve Regurgitation

XTalks

The Harmony pulmonary valve is implanted using a thin catheter with a collapsed Harmony valve on the end. The catheter carrying the valve is inserted through a vein in the groin or in the neck into the right side of the heart and into the RVOT where it is placed into position.

article thumbnail

FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19

The Pharma Data

FDA Approves First Over-the-Counter Fully At-Home Test for COVID-19. Last week, the FDA approved a different at-home test, but it requires samples to be mailed to a lab to get the results. Professional. TUESDAY, Dec. Food and Drug Administration. Results are delivered by smartphone in as little as 20 minutes.

article thumbnail

New Diagnostic Drug Flyrcado Enhances Coronary Artery Disease Diagnosis

XTalks

GE HealthCare’s newly US Food and Drug Administration (FDA)- approved flurpiridaz F 18 positron emission tomography (PET) radiotracer, Flyrcado, could offer a new approach to diagnosing coronary artery disease (CAD). These products exemplify the company’s ongoing efforts to advance molecular imaging.

article thumbnail

Ultravist (Iopromide) Paves New Path in Breast Cancer Detection

XTalks

“The approval of Ultravist-300 and -370 in contrast-enhanced mammography gives physicians a new imaging option where conventional mammography might not be enough,” said Dr. Konstanze Diefenbach, head of Radiology Research and Development at Bayer, in the company’s news release. “We